Biotinylation of platelets for transfusion purposes a novel method to label platelets in a closed system.
Journal
Transfusion
ISSN: 1537-2995
Titre abrégé: Transfusion
Pays: United States
ID NLM: 0417360
Informations de publication
Date de publication:
09 2019
09 2019
Historique:
received:
05
03
2019
revised:
27
05
2019
accepted:
10
06
2019
pubmed:
19
7
2019
medline:
10
6
2020
entrez:
19
7
2019
Statut:
ppublish
Résumé
Labeling of platelets (PLTs) is required to measure the recovery and survival of transfused PLTs in vivo. Currently a radioactive method is used to label PLTs. However, application of those radiolabeling methods is limited by both safety issues and the inability to isolate transfused PLTs from the circulation. Biotin-labeled PLTs are an attractive nonradioactive option. However, no validated protocol to biotinylate PLTs is currently available for human studies. Six PLT concentrates (PCs) were subaliquoted and biotinylated on Days 1 and 7 of storage. To distinguish the effect of the processing steps from the effects of biotin incubation, two control groups were used: 1) "sham" samples were processed without the biotinylation reagent and 2) control samples were assessed without any processing other than the PC isolation. For the biotinylation procedure, 50 mL of PCs was washed twice and incubated with 5 mg/L biotin for 30 minutes in a closed system. As measures of PLT activation, phosphatidylserine exposure and CD62p expression were assessed. After biotinylation, 98.4% ± 0.9% of PLTs were labeled. PLT counts, pH, and "swirling" were within the range accepted by the Dutch blood bank for standard PLT products. Biotinylated PLTs were more activated compared than controles but not more than sham samples, but were more activated than the controls. We developed a standardized and reproducible protocol according to Good Practice Guidelines standards, for biotin labeling of PLTs for clinical purposes. This method can be applied as nonradioactive alternative assess survival and recovery of transfused PLTs in vivo.
Sections du résumé
BACKGROUND
Labeling of platelets (PLTs) is required to measure the recovery and survival of transfused PLTs in vivo. Currently a radioactive method is used to label PLTs. However, application of those radiolabeling methods is limited by both safety issues and the inability to isolate transfused PLTs from the circulation. Biotin-labeled PLTs are an attractive nonradioactive option. However, no validated protocol to biotinylate PLTs is currently available for human studies.
STUDY DESIGN AND METHODS
Six PLT concentrates (PCs) were subaliquoted and biotinylated on Days 1 and 7 of storage. To distinguish the effect of the processing steps from the effects of biotin incubation, two control groups were used: 1) "sham" samples were processed without the biotinylation reagent and 2) control samples were assessed without any processing other than the PC isolation. For the biotinylation procedure, 50 mL of PCs was washed twice and incubated with 5 mg/L biotin for 30 minutes in a closed system. As measures of PLT activation, phosphatidylserine exposure and CD62p expression were assessed.
RESULTS
After biotinylation, 98.4% ± 0.9% of PLTs were labeled. PLT counts, pH, and "swirling" were within the range accepted by the Dutch blood bank for standard PLT products. Biotinylated PLTs were more activated compared than controles but not more than sham samples, but were more activated than the controls.
CONCLUSION
We developed a standardized and reproducible protocol according to Good Practice Guidelines standards, for biotin labeling of PLTs for clinical purposes. This method can be applied as nonradioactive alternative assess survival and recovery of transfused PLTs in vivo.
Identifiants
pubmed: 31318461
doi: 10.1111/trf.15451
pmc: PMC6852179
doi:
Substances chimiques
Biotin
6SO6U10H04
Types de publication
Journal Article
Validation Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
2964-2973Informations de copyright
© 2019 The Authors. Transfusion published by Wiley Periodicals, Inc. on behalf of AABB.
Références
Transfusion. 1998 Mar;38(3):242-6
pubmed: 9563403
Transfus Apher Sci. 2010 Feb;42(1):53-61
pubmed: 19931490
Transfusion. 2006 Feb;46(2):257-64
pubmed: 16441604
Transfusion. 1999 Feb;39(2):149-55
pubmed: 10037124
Transfusion. 2015 Aug;55(8):1900-8
pubmed: 25752624
Yeast. 1999 Jul;15(10A):813-20
pubmed: 10407261
Transfusion. 2007 Oct;47(10):1889-95
pubmed: 17880616
Vox Sang. 2005 Feb;88(2):122-9
pubmed: 15720610
Transfusion. 2012 Apr;52(4):819-27
pubmed: 21981439
Transfusion. 2012 Apr;52(4):742-51
pubmed: 21981629
Anal Biochem. 1985 May 15;147(1):197-209
pubmed: 4025817
Transfusion. 2018 Apr;58(4):896-904
pubmed: 29446461
Transfusion. 1999 May;39(5):506-14
pubmed: 10336001
Transfusion. 1999 Oct;39(10):1065-9
pubmed: 10532599
Transfusion. 2014 Jun;54(6):1610-8
pubmed: 24329960
J Immunol Methods. 1985 Dec 17;85(1):195-202
pubmed: 4078309
Br J Haematol. 1993 Dec;85(4):729-35
pubmed: 7918037
Br J Haematol. 2005 Sep;130(5):791-4
pubmed: 16115139
Transfusion. 2017 Oct;57(10):2373-2380
pubmed: 28703861
Transfusion. 2017 Jun;57(6):1488-1496
pubmed: 28261808
Transfusion. 2004 Jan;44(1):131-3
pubmed: 14692979
Exp Hematol. 1995 Aug;23(9):996-1001
pubmed: 7635185
J Clin Invest. 1986 Jul;78(1):130-7
pubmed: 2941452
Br J Haematol. 1988 Dec;70(4):491-3
pubmed: 3146342